<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="discussion" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Front Neurosci</journal-id>
<journal-id journal-id-type="iso-abbrev">Front Neurosci</journal-id>
<journal-id journal-id-type="publisher-id">Front. Neurosci.</journal-id>
<journal-title-group>
<journal-title>Frontiers in Neuroscience</journal-title>
</journal-title-group>
<issn pub-type="ppub">1662-4548</issn>
<issn pub-type="epub">1662-453X</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">30534048</article-id>
<article-id pub-id-type="pmc">6275198</article-id>
<article-id pub-id-type="doi">10.3389/fnins.2018.00873</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Neuroscience</subject>
<subj-group>
<subject>Opinion</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>ADNP Regulates Cognition: A Multitasking Protein</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Gozes</surname>
<given-names>Illana</given-names>
</name>
<xref ref-type="corresp" rid="c001">
<sup>*</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/65420/overview" xlink:type="simple"></uri>
</contrib>
</contrib-group>
<aff><institution>Laboratory for Molecular Neuroendocrinology, Department of Human Molecular Genetics and Biochemistry, Sackler Faculty of Medicine, Sagol School of Neuroscience and Adams Super Center for Brain Studies, Tel Aviv University</institution>, <addr-line>Tel Aviv</addr-line>, <country>Israel</country></aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited by: Mark P. Burns, Georgetown University, United States</p>
</fn>
<fn fn-type="edited-by">
<p>Reviewed by: Corrado Romano, Associazione Oasi Maria SS. Onlus (IRCCS), Italy</p>
</fn>
<corresp id="c001">*Correspondence: Illana Gozes <email>igozes@tauex.tau.ac.il</email></corresp>
<fn fn-type="other" id="fn001">
<p>This article was submitted to Neurodegeneration, a section of the journal Frontiers in Neuroscience</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>26</day>
<month>11</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="collection">
<year>2018</year>
</pub-date>
<volume>12</volume>
<elocation-id>873</elocation-id>
<history>
<date date-type="received">
<day>04</day>
<month>10</month>
<year>2018</year>
</date>
<date date-type="accepted">
<day>08</day>
<month>11</month>
<year>2018</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright © 2018 Gozes.</copyright-statement>
<copyright-year>2018</copyright-year>
<copyright-holder>Gozes</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p>
</license>
</permissions>
<kwd-group>
<kwd>ADNP (activity dependent neuroprotective protein)</kwd>
<kwd>ADNP gene</kwd>
<kwd>cognition</kwd>
<kwd>protein interaction</kwd>
<kwd>neurodegenaration</kwd>
</kwd-group>
<funding-group>
<award-group>
<funding-source id="cn001">Israel Science Foundation<named-content content-type="fundref-id">10.13039/501100003977</named-content></funding-source>
</award-group>
</funding-group>
<counts>
<fig-count count="1"></fig-count>
<table-count count="0"></table-count>
<equation-count count="0"></equation-count>
<ref-count count="49"></ref-count>
<page-count count="5"></page-count>
<word-count count="3487"></word-count>
</counts>
</article-meta>
</front>
<body>
<sec id="s1" sec-type="intro">
<title>Introduction</title>
<p>With the advantage of rapid progress of DNA/RNA sequencing techniques, it has become feasible to identify the cause of developmental disorders encompassing intellectual disabilities to single <italic>de novo</italic> mutated genes (e.g., Larsen et al., <xref ref-type="bibr" rid="B27">2016</xref>; Deciphering Developmental Disorders, <xref ref-type="bibr" rid="B9">2017</xref>; Stessman et al., <xref ref-type="bibr" rid="B42">2017</xref>). It is my opinion that we should study in depth, the leading identified genes, to acquire better understanding of the molecular basis for human cognitive functions. Furthermore, from a translational science point of view, understanding genes regulating cognition will facilitate drug development to currently untreatable devastating disease, which hamper cognition. Here, I focus on activity-dependent neuroprotective protein (ADNP) (Gozes et al., <xref ref-type="bibr" rid="B16">2018</xref>) showing a tight association with cognition, and in my opinion, a key gene regulating cognitive functions.</p>
</sec>
<sec id="s2">
<title>Activity-dependent neuroprotective protein (ADNP)</title>
<p>Our original studies identified vasoactive intestinal peptide (VIP) (Bodner et al., <xref ref-type="bibr" rid="B6">1985</xref>) as a gene/protein highly expressed at the time of synapse formation (Gozes et al., <xref ref-type="bibr" rid="B19">1987</xref>), which was translated to VIP-associated neuroprotection (Brenneman and Eiden, <xref ref-type="bibr" rid="B8">1986</xref>) and VIP-related synaptogenesis, through astrocyte activation (Blondel et al., <xref ref-type="bibr" rid="B5">2000</xref>). Astrocyte activation entailed secretion of protein growth factors, leading to the cloning/discovery of ADNP and its active neuroprotective site, NAP (NAPVSIPQ) (Bassan et al., <xref ref-type="bibr" rid="B4">1999</xref>; Zamostiano et al., <xref ref-type="bibr" rid="B48">2001</xref>). To elucidate ADNP's <italic>in vivo</italic> activity we knocked out the <italic>ADNP</italic> gene and showed that this gene is essential for neural tube closure and brain formation (Pinhasov et al., <xref ref-type="bibr" rid="B38">2003</xref>). At the single cell level, ADNP is found in the nucleus and upon neuronal maturation, the protein is found also in the cytoplasm with specific RNA silencing resulting in loss of microtubules/loss of neurites (Mandel et al., <xref ref-type="bibr" rid="B34">2008</xref>). While complete knockout of ADNP is lethal, haploinsufficient (heterozygous) mice survive, showing cognitive impairment (Vulih-Shultzman et al., <xref ref-type="bibr" rid="B46">2007</xref>). Further results indicate microtubule insufficiency, reduced axonal transport (Amram et al., <xref ref-type="bibr" rid="B2">2016</xref>) and reduced dendritic spines (Hacohen-Kleiman et al., <xref ref-type="bibr" rid="B21">2018</xref>) in the <italic>Adnp</italic><sup>+/−</sup> mice. These findings are in line with patient results showing intellectual disabilities in case of ADNP gene heterozygous microdeletion or truncating mutation (Borozdin et al., <xref ref-type="bibr" rid="B7">2007</xref>; Vandeweyer et al., <xref ref-type="bibr" rid="B45">2014</xref>; Huynh et al., <xref ref-type="bibr" rid="B24">2018</xref>). Given the fact that ADNP is a large protein it includes many identified signature motifs for macromolecular interactions and here I will concentrate on the ADNP motifs, protein interactors and the strong link to cognition.</p>
</sec>
<sec id="s3">
<title>ADNP binding motifs</title>
<p>ADNP contains a nuclear localization signal (NLS) and a homeobox domain profile (Bassan et al., <xref ref-type="bibr" rid="B4">1999</xref>; Zamostiano et al., <xref ref-type="bibr" rid="B48">2001</xref>). ADNP has heterochromatin protein 1 (HP1) binding domains (Mandel et al., <xref ref-type="bibr" rid="B33">2007</xref>; Mosch et al., <xref ref-type="bibr" rid="B36">2011</xref>) and interacts with DNA in a sequence-specific manner, as well as with HP1 (Mandel et al., <xref ref-type="bibr" rid="B33">2007</xref>; Mosch et al., <xref ref-type="bibr" rid="B36">2011</xref>) and chromodomain-helicase-DNA-binding protein 4 (CHD4) (Ostapcuk et al., <xref ref-type="bibr" rid="B37">2018</xref>). ADNP was discovered to bind and affect the SWItch/Sucrose Non-Fermentable (SWI/SNF) chromatin remodeling complex (Mandel and Gozes, <xref ref-type="bibr" rid="B32">2007</xref>) also associated with alternative RNA splicing (Schirer et al., <xref ref-type="bibr" rid="B39">2014</xref>). The DNA/chromatin binding characteristics have been further implicated in promoter/control gene specific regions for ADNP binding and direct regulation of RNA expression (Mandel et al., <xref ref-type="bibr" rid="B33">2007</xref>; Dresner et al., <xref ref-type="bibr" rid="B11">2012</xref>). Complete gene array analysis, RNA-seq and high-throughput platform BioMark™ HD System (Fluidigm) identified hundreds of ADNP regulated transcripts (Mandel et al., <xref ref-type="bibr" rid="B33">2007</xref>; Amram et al., <xref ref-type="bibr" rid="B2">2016</xref>; Hacohen-Kleiman et al., <xref ref-type="bibr" rid="B21">2018</xref>) suggesting a master gene regulator function.</p>
<p>In the cytoplasm, ADNP was found to bind eukaryotic initiation factor 4E (Eif4e), implicating an involvement in the protein translation machinery (Malishkevich et al., <xref ref-type="bibr" rid="B30">2015</xref>) and the autophagy complex, by direct binding to microtubule associated protein 1 light chain 3B (LC3B) (Merenlender-Wagner et al., <xref ref-type="bibr" rid="B35">2015</xref>; Sragovich et al., <xref ref-type="bibr" rid="B40">2017</xref>). ADNP provides potent neurotrophic/neuroprotective activity that can be attributed, at least in part, to NAP (davunetide, AL-108 or CP201 (Bassan et al., <xref ref-type="bibr" rid="B4">1999</xref>; Gozes et al., <xref ref-type="bibr" rid="B16">2018</xref>). In short, the SIP domain in NAP interacts with microtubule end binding proteins (EB1 and EB3) enhancing ADNP (Esteves et al., <xref ref-type="bibr" rid="B12">2014</xref>) and tau (Ivashko-Pachima et al., <xref ref-type="bibr" rid="B25">2017</xref>) interaction with microtubules. This SxIP (SKIP) domain in NAP further protects against deficits in axonal transport occurring because of ADNP deficiency (Amram et al., <xref ref-type="bibr" rid="B2">2016</xref>) and NAP enhances ADNP interaction with the autophagosome membrane protein LC3B (Merenlender-Wagner et al., <xref ref-type="bibr" rid="B35">2015</xref>). <italic>In vivo</italic> NAP restores multiple anomalies caused by ADNP haploinsufficiency (Vulih-Shultzman et al., <xref ref-type="bibr" rid="B46">2007</xref>; Hacohen-Kleiman et al., <xref ref-type="bibr" rid="B21">2018</xref>). Lastly, our original studies have shown that ADNP has a glutaredoxin active site (Bassan et al., <xref ref-type="bibr" rid="B4">1999</xref>).</p>
</sec>
<sec id="s4">
<title>Proteins interacting with ADNP</title>
<p>Ten ADNP-interacting proteins were identified when analyzing (string) for human genes and 9 proteins when searching for mouse associations, with 6 overlapping proteins (Figure <xref ref-type="fig" rid="F1">1</xref>). Some of these proteins are described in the section above. The common mouse and human proteins, not described above, include ZFP161–Zinc finger protein 161 homolog (mouse), which is a transcriptional activator of the dopamine transporter (DAT). ZFP161 also acts as a repressor of the FMR1 gene (fragile X syndrome). We have originally shown that ZF5 is linked to regulation by ADNP in the developing mouse embryos (Mandel et al., <xref ref-type="bibr" rid="B33">2007</xref>). Another shared mouse and human protein, EBNA1BP2 is linked to early onset Alzheimer's disease (<ext-link ext-link-type="uri" xlink:href="https://www.malacards.org/card/early_onset_familial_alzheimer_disease">https://www.malacards.org/card/early_onset_familial_alzheimer_disease</ext-link>). A third one, SAP18 enhances the ability of SIN3-HDAC1-mediated transcriptional repression. When tethered to the promoter, it can direct the formation of a repressive complex to core histone proteins. SAP18 is an auxiliary component of the splicing-dependent multiprotein exon junction complex (EJC) deposited at splice junction on mRNAs, and our laboratory has shown interaction of ADNP with the RNA splicing machinery (Schirer et al., <xref ref-type="bibr" rid="B39">2014</xref>). ADNP-interacting proteins described for either human or mouse, include actin-interacting proteins (EMD – nuclear), SEPT2—cytoplasmic and Spna2—associated with the cytoskeleton. Other interacting proteins are NFIA, linked to viral infection, PHGDH, linked to cytoplasmic energy metabolism and SAP18b (Gm10094, <ext-link ext-link-type="uri" xlink:href="http://www.informatics.jax.org/marker/MGI:1277978">http://www.informatics.jax.org/marker/MGI:1277978</ext-link>).</p>
<fig id="F1" position="float">
<label>Figure 1</label>
<caption>
<p>The illustration shows ADNP interactions (String analysis, <ext-link ext-link-type="uri" xlink:href="https://string-db.org/cgi/network.pl?taskId=P3YfAA8ZrZzy">https://string-db.org/cgi/network.pl?taskId=P3YfAA8ZrZzy</ext-link>). Edges represent protein-protein associations, Known-interactions from curated databases are shown in light blue, experimentally determined are in magenta. Predicted Interactions include, gene neighborhood (green) gene fusions (red) gene co-occurrence (violet), textmining (light green), co-expression (black) and protein homology (light violet). References cited in the figure and not cited above include (Havugimana et al., <xref ref-type="bibr" rid="B22">2012</xref>; Joshi et al., <xref ref-type="bibr" rid="B26">2013</xref>; Diner et al., <xref ref-type="bibr" rid="B10">2015</xref>).</p>
</caption>
<graphic xlink:href="fnins-12-00873-g0001"></graphic>
</fig>
</sec>
<sec id="s5">
<title>ADNP and cognition</title>
<p>Our studies showed that VIP and VIP derivatives protected against Alzheimer-like pathology (Gozes et al., <xref ref-type="bibr" rid="B14">1996</xref>, <xref ref-type="bibr" rid="B18">1999</xref>). Furthermore, the VIP receptor, VPAC2, controlling ADNP expression (Zusev and Gozes, <xref ref-type="bibr" rid="B49">2004</xref>), has been linked to schizophrenia and autism spectrum disorders (Vacic et al., <xref ref-type="bibr" rid="B43">2011</xref>; Ago et al., <xref ref-type="bibr" rid="B1">2018</xref>) and VIP regulates ADNP expression <italic>in vivo</italic> (Giladi et al., <xref ref-type="bibr" rid="B13">2007</xref>). Our discovery of the requirement of ADNP for brain formation (Pinhasov et al., <xref ref-type="bibr" rid="B38">2003</xref>) coupled with the finding that a major phenotypic outcome of ADNP haploinsufficency in mice leads to cognitive impairments, placed ADNP as a key regulatory gene for brain function (Vulih-Shultzman et al., <xref ref-type="bibr" rid="B46">2007</xref>). The direct involvement of ADNP in cognitive function was reported in our 2007 <italic>Adnp</italic> haploinsufficient mouse model (Vulih-Shultzman et al., <xref ref-type="bibr" rid="B46">2007</xref>) coupled with a paper showing that deletion in the chromosomal area including ADNP [20q12–13.2 (Zamostiano et al., <xref ref-type="bibr" rid="B48">2001</xref>)] specifically, 20q13.13–q13.2 (Borozdin et al., <xref ref-type="bibr" rid="B7">2007</xref>) resulted in developmental delays and intellectual disabilities in humans. Both animal studies (Malishkevich et al., <xref ref-type="bibr" rid="B30">2015</xref>; Amram et al., <xref ref-type="bibr" rid="B2">2016</xref>; Hacohen-Kleiman et al., <xref ref-type="bibr" rid="B21">2018</xref>) as well as the human studies were repeated and extended showing axonal/synaptic/behavioral dysfunctions at the mouse level (Amram et al., <xref ref-type="bibr" rid="B2">2016</xref>; Hacohen-Kleiman et al., <xref ref-type="bibr" rid="B21">2018</xref>) mirroring the human situation when the <italic>ADNP</italic> gene is partially deleted (Huynh et al., <xref ref-type="bibr" rid="B24">2018</xref>) or pathologically mutated (Helsmoortel et al., <xref ref-type="bibr" rid="B23">2014</xref>; Vandeweyer et al., <xref ref-type="bibr" rid="B45">2014</xref>; Gozes et al., <xref ref-type="bibr" rid="B15">2015</xref>, <xref ref-type="bibr" rid="B17">2017a</xref>,<xref ref-type="bibr" rid="B20">b</xref>, <xref ref-type="bibr" rid="B16">2018</xref>; Arnett et al., <xref ref-type="bibr" rid="B3">2018</xref>; Van Dijck et al., <xref ref-type="bibr" rid="B44">2018</xref>). Over the last 4 years it became apparent that the mutated <italic>ADNP</italic> gene is consistently reported as one of the most frequent causes of syndromic autism and intellectual disability (Helsmoortel et al., <xref ref-type="bibr" rid="B23">2014</xref>; Larsen et al., <xref ref-type="bibr" rid="B27">2016</xref>; Deciphering Developmental Disorders, <xref ref-type="bibr" rid="B9">2017</xref>; Stessman et al., <xref ref-type="bibr" rid="B42">2017</xref>).</p>
<p>Notably, the involvement of ADNP in cognitive performance is not limited to the <italic>ADNP</italic> syndrome but is extended to schizophrenia (Merenlender-Wagner et al., <xref ref-type="bibr" rid="B35">2015</xref>) and Alzheimer's disease (Malishkevich et al., <xref ref-type="bibr" rid="B31">2016</xref>) with <italic>ADNP</italic> transcripts dysregulated in lymphocytes in both diseases and with ADNP blood levels correlating with intelligence (Malishkevich et al., <xref ref-type="bibr" rid="B31">2016</xref>). Thus, the current opinion combines mechanisms to cognitive protection.</p>
<p>Furthermore, NAP activity is not limited to the mouse model, but has shown efficacy in amnestic mild cognitive impairment patients, prodromal to Alzheimer's disease (protecting short term memory) and in schizophrenia patients (protecting functional activities of daily living as reviewed; Magen and Gozes, <xref ref-type="bibr" rid="B28">2013</xref>, <xref ref-type="bibr" rid="B29">2014</xref>). Currently, Coronis Neurosciences (<ext-link ext-link-type="uri" xlink:href="http://www.coronisns.com">www.coronisns.com</ext-link>) is developing NAP (CP201) for the ADNP syndrome.</p>
</sec>
<sec id="s6" sec-type="conclusions">
<title>Conclusions</title>
<p>This opinion article connects ADNP to a network of proteins linked with cognitive abilities. As many cases within the autism spectrum disorders and developmental disorders are caused by single gene mutations, it is of great interest to understand the protein interactions to get a comprehensive understanding of the molecular basis of cognition. Specifically, in the case of ADNP, which has been correlated with intelligence in the developing child and in the elderly, in autism spectrum disorders, the ADNP syndrome, in Alzheimer's disease and cognitive impairments associated with schizophrenia. The case of ADNP is unique with the identification of its active neuroprotective site, NAP. Outlined above are protein interacting with the multitasking ADNP, which are linked in part to neurodevelopment and cognition. For example, mutations in CHD4 (OMIM # 617159) cause neurodevelopmental delays, chromatin remodelers have been associated with cognition (Wenderski and Maze, <xref ref-type="bibr" rid="B47">2016</xref>), Eif4e has been tightly linked with autism (St Clair and Johnstone, <xref ref-type="bibr" rid="B41">2018</xref>) and autophagy with autism, brain degeneration and schizophrenia (Sragovich et al., <xref ref-type="bibr" rid="B40">2017</xref>). Finally, ADNP's interaction with cytoskeletal proteins shapes the synapse and contributes to brain plasticity (Gozes et al., <xref ref-type="bibr" rid="B16">2018</xref>; Hacohen-Kleiman et al., <xref ref-type="bibr" rid="B21">2018</xref>). Understanding ADNP multitasks and interacting proteins, will allow the development of NAP and pipeline for other related diseases, syndromes affected by single gene mutations and allow cross-over drug repositioning clinical developments for the benefit of the cognitively impaired patient, families and society at large.</p>
</sec>
<sec id="s7">
<title>Author contributions</title>
<p>The author confirms being the sole contributor of this work and has approved it for publication.</p>
<sec>
<title>Conflict of interest statement</title>
<p>IG is the Chief Scientific Officer of Coronis Neurosciences, developing CP201 (under patent protection and license from Ramot at Tel Aviv University).</p>
</sec>
</sec>
</body>
<back>
<fn-group>
<fn fn-type="financial-disclosure">
<p><bold>Funding.</bold> Research was supported by funds from the Israel Science Foundation (ISF) grant (1424/14), ERA-NET neuron AUTYSM, AMN Foundation, Drs. Ronith and Armand Stemmer and Mr. Arthur Gerbi (French Friends of Tel Aviv University), as well as Canadian (Mrs. Anne and Mr. Alex Cohen) and Spanish Friends of Tel Aviv University.</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="B1">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ago</surname><given-names>Y.</given-names></name><name><surname>Hayata</surname><given-names>A.</given-names></name><name><surname>Hashimoto</surname><given-names>H.</given-names></name></person-group> (<year>2018</year>). <article-title>[Pathophysiological implication of the VPAC2 receptor in psychiatric disorders]</article-title>. <source/>Nihon Yakurigaku Zasshi. <volume>151</volume>, <fpage>249</fpage>–<lpage>253</lpage>. <pub-id pub-id-type="doi">10.1254/fpj.151.249</pub-id><pub-id pub-id-type="pmid">29887574</pub-id></mixed-citation>
</ref>
<ref id="B2">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Amram</surname><given-names>N.</given-names></name><name><surname>Hacohen-Kleiman</surname><given-names>G.</given-names></name><name><surname>Sragovich</surname><given-names>S.</given-names></name><name><surname>Malishkevich</surname><given-names>A.</given-names></name><name><surname>Katz</surname><given-names>J.</given-names></name><name><surname>Touloumi</surname><given-names>O.</given-names></name><etal></etal></person-group>. (<year>2016</year>). <article-title>Sexual divergence in microtubule function: the novel intranasal microtubule targeting SKIP normalizes axonal transport and enhances memory</article-title>. <source/>Mol. Psychiatry
<volume>21</volume>, <fpage>1467</fpage>–<lpage>1476</lpage>. <pub-id pub-id-type="doi">10.1038/mp.2015.208</pub-id><pub-id pub-id-type="pmid">26782054</pub-id></mixed-citation>
</ref>
<ref id="B3">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arnett</surname><given-names>A. B.</given-names></name><name><surname>Rhoads</surname><given-names>C. L.</given-names></name><name><surname>Hoekzema</surname><given-names>K.</given-names></name><name><surname>Turner</surname><given-names>T. N.</given-names></name><name><surname>Gerdts</surname><given-names>J.</given-names></name><name><surname>Wallace</surname><given-names>A. S.</given-names></name><etal></etal></person-group>. (<year>2018</year>). <article-title>The autism spectrum phenotype in ADNP syndrome</article-title>. <source/>Autism Res.
<volume>11</volume>, <fpage>1300</fpage>–<lpage>1310</lpage>. <pub-id pub-id-type="doi">10.1002/aur.1980</pub-id><pub-id pub-id-type="pmid">30107084</pub-id></mixed-citation>
</ref>
<ref id="B4">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bassan</surname><given-names>M.</given-names></name><name><surname>Zamostiano</surname><given-names>R.</given-names></name><name><surname>Davidson</surname><given-names>A.</given-names></name><name><surname>Pinhasov</surname><given-names>A.</given-names></name><name><surname>Giladi</surname><given-names>E.</given-names></name><name><surname>Perl</surname><given-names>O.</given-names></name><etal></etal></person-group>. (<year>1999</year>). <article-title>Complete sequence of a novel protein containing a femtomolar-activity-dependent neuroprotective peptide</article-title>. <source/>J. Neurochem.
<volume>72</volume>, <fpage>1283</fpage>–<lpage>1293</lpage>.<pub-id pub-id-type="pmid">10037502</pub-id></mixed-citation>
</ref>
<ref id="B5">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blondel</surname><given-names>O.</given-names></name><name><surname>Collin</surname><given-names>C.</given-names></name><name><surname>McCarran</surname><given-names>W. J.</given-names></name><name><surname>Zhu</surname><given-names>S.</given-names></name><name><surname>Zamostiano</surname><given-names>R.</given-names></name><name><surname>Gozes</surname><given-names>I.</given-names></name><etal></etal></person-group>. (<year>2000</year>). <article-title>A glia-derived signal regulating neuronal differentiation</article-title>. <source/>J. Neurosci.
<volume>20</volume>, <fpage>8012</fpage>–<lpage>8020</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.20-21-08012.2000</pub-id><pub-id pub-id-type="pmid">11050122</pub-id></mixed-citation>
</ref>
<ref id="B6">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bodner</surname><given-names>M.</given-names></name><name><surname>Fridkin</surname><given-names>M.</given-names></name><name><surname>Gozes</surname><given-names>I.</given-names></name></person-group> (<year>1985</year>). <article-title>Coding sequences for vasoactive intestinal peptide and PHM-27 peptide are located on two adjacent exons in the human genome</article-title>. <source/>Proc. Nat. Acad. Sci. U.S.A.
<volume>82</volume>, <fpage>3548</fpage>–<lpage>3551</lpage>.<pub-id pub-id-type="pmid">2987932</pub-id></mixed-citation>
</ref>
<ref id="B7">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Borozdin</surname><given-names>W.</given-names></name><name><surname>Graham</surname><given-names>J. M.</given-names><suffix>Jr.</suffix></name><name><surname>Bohm</surname><given-names>D.</given-names></name><name><surname>Bamshad</surname><given-names>M. J.</given-names></name><name><surname>Spranger</surname><given-names>S.</given-names></name><name><surname>Burke</surname><given-names>L.</given-names></name><etal></etal></person-group>. (<year>2007</year>). <article-title>Multigene deletions on chromosome 20q13.13-q13.2 including SALL4 result in an expanded phenotype of Okihiro syndrome plus developmental delay</article-title>. <source/>Hum. Mutat.
<volume>28</volume>:<fpage>830</fpage>. <pub-id pub-id-type="doi">10.1002/humu.9502</pub-id><pub-id pub-id-type="pmid">17623483</pub-id></mixed-citation>
</ref>
<ref id="B8">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brenneman</surname><given-names>D. E.</given-names></name><name><surname>Eiden</surname><given-names>L. E.</given-names></name></person-group> (<year>1986</year>). <article-title>Vasoactive intestinal peptide and electrical activity influence neuronal survival</article-title>. <source/>Proc. Natl Acad. Sci. U.S. A.
<volume>83</volume>, <fpage>1159</fpage>–<lpage>1162</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.83.4.1159</pub-id><pub-id pub-id-type="pmid">3456568</pub-id></mixed-citation>
</ref>
<ref id="B9">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><collab>Deciphering Developmental Disorders</collab></person-group> (<year>2017</year>). <article-title>Prevalence and architecture of <italic>de novo</italic> mutations in developmental disorders</article-title>. <source/>Nature
<volume>542</volume>, <fpage>433</fpage>–<lpage>438</lpage>. <pub-id pub-id-type="doi">10.1038/nature21062</pub-id><pub-id pub-id-type="pmid">28135719</pub-id></mixed-citation>
</ref>
<ref id="B10">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Diner</surname><given-names>B. A.</given-names></name><name><surname>Li</surname><given-names>T.</given-names></name><name><surname>Greco</surname><given-names>T. M.</given-names></name><name><surname>Crow</surname><given-names>M. S.</given-names></name><name><surname>Fuesler</surname><given-names>J. A.</given-names></name><name><surname>Wang</surname><given-names>J.</given-names></name><etal></etal></person-group>. (<year>2015</year>). <article-title>The functional interactome of PYHIN immune regulators reveals IFIX is a sensor of viral DNA</article-title>. <source/>Mol. Syst. Biol.
<volume>11</volume>:<fpage>787</fpage>. <pub-id pub-id-type="doi">10.15252/msb.20145808</pub-id><pub-id pub-id-type="pmid">25665578</pub-id></mixed-citation>
</ref>
<ref id="B11">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dresner</surname><given-names>E.</given-names></name><name><surname>Malishkevich</surname><given-names>A.</given-names></name><name><surname>Arviv</surname><given-names>C.</given-names></name><name><surname>Leibman Barak</surname><given-names>S.</given-names></name><name><surname>Alon</surname><given-names>S.</given-names></name><name><surname>Ofir</surname><given-names>R.</given-names></name><etal></etal></person-group>. (<year>2012</year>). <article-title>Novel evolutionary-conserved role for the activity-dependent neuroprotective protein (ADNP) family that is important for erythropoiesis</article-title>. <source/>J. Biol. Chem.
<volume>287</volume>, <fpage>40173</fpage>–<lpage>40185</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M112.387027</pub-id><pub-id pub-id-type="pmid">23071114</pub-id></mixed-citation>
</ref>
<ref id="B12">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Esteves</surname><given-names>A. R.</given-names></name><name><surname>Gozes</surname><given-names>I.</given-names></name><name><surname>Cardoso</surname><given-names>S. M.</given-names></name></person-group> (<year>2014</year>). <article-title>The rescue of microtubule-dependent traffic recovers mitochondrial function in Parkinson's disease</article-title>. <source/>Biochim. Biophys. Acta
<volume>1842</volume>, <fpage>7</fpage>–<lpage>21</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbadis.2013.10.003</pub-id><pub-id pub-id-type="pmid">24120997</pub-id></mixed-citation>
</ref>
<ref id="B13">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Giladi</surname><given-names>E.</given-names></name><name><surname>Hill</surname><given-names>J. M.</given-names></name><name><surname>Dresner</surname><given-names>E.</given-names></name><name><surname>Stack</surname><given-names>C. M.</given-names></name><name><surname>Gozes</surname><given-names>I.</given-names></name></person-group> (<year>2007</year>). <article-title>Vasoactive intestinal peptide (VIP) regulates activity-dependent neuroprotective protein (ADNP) expression <italic>in vivo</italic></article-title>. <source/>J. Mol. Neurosci.
<volume>33</volume>, <fpage>278</fpage>–<lpage>283</lpage>. <pub-id pub-id-type="doi">10.1007/s12031-007-9003-0</pub-id><pub-id pub-id-type="pmid">17952637</pub-id></mixed-citation>
</ref>
<ref id="B14">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gozes</surname><given-names>I.</given-names></name><name><surname>Bardea</surname><given-names>A.</given-names></name><name><surname>Reshef</surname><given-names>A.</given-names></name><name><surname>Zamostiano</surname><given-names>R.</given-names></name><name><surname>Zhukovsky</surname><given-names>S.</given-names></name><name><surname>Rubinraut</surname><given-names>S.</given-names></name><etal></etal></person-group>. (<year>1996</year>). <article-title>Neuroprotective strategy for Alzheimer disease: intranasal administration of a fatty neuropeptide</article-title>. <source/>Proc. Natl Acad. Sci. U.S.A.
<volume>93</volume>, <fpage>427</fpage>–<lpage>432</lpage>.<pub-id pub-id-type="pmid">8552653</pub-id></mixed-citation>
</ref>
<ref id="B15">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gozes</surname><given-names>I.</given-names></name><name><surname>Helsmoortel</surname><given-names>C.</given-names></name><name><surname>Vandeweyer</surname><given-names>G. N</given-names></name><name><surname>Van der Aa</surname><given-names>Kooy F.</given-names></name><name><surname>Sermone</surname><given-names>S. B.</given-names></name></person-group> (<year>2015</year>). <article-title>The Compassionate side of neuroscience: tony sermone's undiagnosed genetic journey–ADNP mutation</article-title>. <source/>J. Mol. Neurosci.
<volume>56</volume>, <fpage>751</fpage>–<lpage>757</lpage>. <pub-id pub-id-type="doi">10.1007/s12031-015-0586-6</pub-id><pub-id pub-id-type="pmid">26168855</pub-id></mixed-citation>
</ref>
<ref id="B16">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gozes</surname><given-names>I.</given-names></name><name><surname>Ivashko-Pachima</surname><given-names>Y.</given-names></name><name><surname>Sayas</surname><given-names>C. L.</given-names></name></person-group> (<year>2018</year>). <article-title>ADNP, a microtubule interacting protein, provides neuroprotection through end binding proteins and tau: an amplifier effect</article-title>. <source/>Front. Mol. Neurosci.
<volume>11</volume>:<fpage>151</fpage>. <pub-id pub-id-type="doi">10.3389/fnmol.2018.00151</pub-id><pub-id pub-id-type="pmid">29765303</pub-id></mixed-citation>
</ref>
<ref id="B17">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gozes</surname><given-names>I.</given-names></name><name><surname>Patterson</surname><given-names>M. C.</given-names></name><name><surname>Van Dijck</surname><given-names>A.</given-names></name><name><surname>Kooy</surname><given-names>R. F.</given-names></name><name><surname>Peeden</surname><given-names>J. N.</given-names></name><name><surname>Eichenberger</surname><given-names>J. A.</given-names></name><etal></etal></person-group>. (<year>2017a</year>). <article-title>The eight and a half year journey of undiagnosed ad: gene sequencing and funding of advanced genetic testing has led to hope and new beginnings</article-title>. <source/>Front. Endocrinol.
<volume>8</volume>:<fpage>107</fpage>. <pub-id pub-id-type="doi">10.3389/fendo.2017.00107</pub-id><pub-id pub-id-type="pmid">28579975</pub-id></mixed-citation>
</ref>
<ref id="B18">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gozes</surname><given-names>I.</given-names></name><name><surname>Perl</surname><given-names>O.</given-names></name><name><surname>Giladi</surname><given-names>E.</given-names></name><name><surname>Davidson</surname><given-names>A.</given-names></name><name><surname>Ashur-Fabian</surname><given-names>O.</given-names></name><name><surname>Rubinraut</surname><given-names>S.</given-names></name><etal></etal></person-group>. (<year>1999</year>). <article-title>Mapping the active site in vasoactive intestinal peptide to a core of four amino acids: neuroprotective drug design</article-title>. <source/>Proc. Natl Acad. Sci. U.S.A.
<volume>96</volume>, <fpage>4143</fpage>–<lpage>4148</lpage>.<pub-id pub-id-type="pmid">10097177</pub-id></mixed-citation>
</ref>
<ref id="B19">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gozes</surname><given-names>I.</given-names></name><name><surname>Shani</surname><given-names>Y.</given-names></name><name><surname>Rostène</surname><given-names>W. H.</given-names></name></person-group> (<year>1987</year>). <article-title>Developmental expression of the VIP-gene in brain and intestine</article-title>. <source/>Brain Res.
<volume>388</volume>, <fpage>137</fpage>–<lpage>148</lpage>. <pub-id pub-id-type="doi">10.1016/0169-328X(87)90007-6</pub-id><pub-id pub-id-type="pmid">2441796</pub-id></mixed-citation>
</ref>
<ref id="B20">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gozes</surname><given-names>I.</given-names></name><name><surname>Van Dijck</surname><given-names>A.</given-names></name><name><surname>Hacohen-Kleiman</surname><given-names>G.</given-names></name><name><surname>Grigg</surname><given-names>I.</given-names></name><name><surname>Karmon</surname><given-names>G.</given-names></name><name><surname>Giladi</surname><given-names>E.</given-names></name><etal></etal></person-group> (<year>2017b</year>). <article-title>Premature primary tooth eruption in cognitive/motor-delayed ADNP-mutated children</article-title>. <source/>Transl. Psychiatry
<volume>7</volume>:<fpage>e1043</fpage>
<pub-id pub-id-type="doi">10.1038/tp.2017.27</pub-id><pub-id pub-id-type="pmid">28221363</pub-id></mixed-citation>
</ref>
<ref id="B21">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hacohen-Kleiman</surname><given-names>G.</given-names></name><name><surname>Sragovich</surname><given-names>S.</given-names></name><name><surname>Karmon</surname><given-names>G.</given-names></name><name><surname>Gao</surname><given-names>A. Y. L.</given-names></name><name><surname>Grigg</surname><given-names>I.</given-names></name><name><surname>Pasmanik-Chor</surname><given-names>M.</given-names></name><etal></etal></person-group>. (<year>2018</year>). <article-title>Activity-dependent neuroprotective protein deficiency models synaptic and developmental phenotypes of autism-like syndrome</article-title>. <source/>J. Clin. Invest.
<volume>128</volume>, <fpage>4956</fpage>–<lpage>4969</lpage>. <pub-id pub-id-type="doi">10.1172/JCI98199</pub-id><pub-id pub-id-type="pmid">30106381</pub-id></mixed-citation>
</ref>
<ref id="B22">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Havugimana</surname><given-names>P. C.</given-names></name><name><surname>Hart</surname><given-names>G. T.</given-names></name><name><surname>Nepusz</surname><given-names>T.</given-names></name><name><surname>Yang</surname><given-names>H.</given-names></name><name><surname>Turinsky</surname><given-names>A. L.</given-names></name><name><surname>Li</surname><given-names>Z.</given-names></name><etal></etal></person-group>. (<year>2012</year>). <article-title>A census of human soluble protein complexes</article-title>. <source/>Cell
<volume>150</volume>, <fpage>1068</fpage>–<lpage>1081</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2012.08.011</pub-id><pub-id pub-id-type="pmid">22939629</pub-id></mixed-citation>
</ref>
<ref id="B23">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Helsmoortel</surname><given-names>C.</given-names></name><name><surname>Vulto-van Silfhout</surname><given-names>A. T.</given-names></name><name><surname>Coe</surname><given-names>B. P.</given-names></name><name><surname>Vandeweyer</surname><given-names>G.</given-names></name><name><surname>Rooms</surname><given-names>L.</given-names></name><name><surname>van den Ende</surname><given-names>J.</given-names></name><etal></etal></person-group>. (<year>2014</year>). <article-title>A SWI/SNF-related autism syndrome caused by de novo mutations in ADNP</article-title>. <source/>Nat. Genet.
<volume>46</volume>, <fpage>380</fpage>–<lpage>384</lpage>. <pub-id pub-id-type="doi">10.1038/ng.2899</pub-id><pub-id pub-id-type="pmid">24531329</pub-id></mixed-citation>
</ref>
<ref id="B24">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huynh</surname><given-names>M. T.</given-names></name><name><surname>Boudry-Labis</surname><given-names>E.</given-names></name><name><surname>Massard</surname><given-names>A.</given-names></name><name><surname>Thuillier</surname><given-names>C.</given-names></name><name><surname>Delobel</surname><given-names>B.</given-names></name><name><surname>Duban-Bedu</surname><given-names>B.</given-names></name><etal></etal></person-group>. (<year>2018</year>). <article-title>A heterozygous microdeletion of 20q13.13 encompassing ADNP gene in a child with Helsmoortel-van der Aa syndrome</article-title>. <source/>Eur. J. Hum. Genet.
<volume>26</volume>, <fpage>1497</fpage>–<lpage>1501</lpage>. <pub-id pub-id-type="doi">10.1038/s41431-018-0165-8</pub-id><pub-id pub-id-type="pmid">29899371</pub-id></mixed-citation>
</ref>
<ref id="B25">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ivashko-Pachima</surname><given-names>Y.</given-names></name><name><surname>Sayas</surname><given-names>C. L.</given-names></name><name><surname>Malishkevich</surname><given-names>A.</given-names></name><name><surname>Gozes</surname><given-names>I.</given-names></name></person-group> (<year>2017</year>). <article-title>ADNP/NAP dramatically increase microtubule end-binding protein-Tau interaction: a novel avenue for protection against tauopathy</article-title>. <source/>Mol. Psychiatry
<volume>22</volume>, <fpage>1335</fpage>–<lpage>1344</lpage>. <pub-id pub-id-type="doi">10.1038/mp.2016.255</pub-id><pub-id pub-id-type="pmid">28115743</pub-id></mixed-citation>
</ref>
<ref id="B26">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Joshi</surname><given-names>P.</given-names></name><name><surname>Greco</surname><given-names>T. M.</given-names></name><name><surname>Guise</surname><given-names>A. J.</given-names></name><name><surname>Luo</surname><given-names>Y.</given-names></name><name><surname>Yu</surname><given-names>F.</given-names></name><name><surname>Nesvizhskii</surname><given-names>A. I.</given-names></name><etal></etal></person-group>. (<year>2013</year>). <article-title>The functional interactome landscape of the human histone deacetylase family</article-title>. <source/>Mol. Syst. Biol.
<volume>9</volume>:<fpage>672</fpage>. <pub-id pub-id-type="doi">10.1038/msb.2013.26</pub-id><pub-id pub-id-type="pmid">23752268</pub-id></mixed-citation>
</ref>
<ref id="B27">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Larsen</surname><given-names>E.</given-names></name><name><surname>Menashe</surname><given-names>I.</given-names></name><name><surname>Ziats</surname><given-names>M. N.</given-names></name><name><surname>Pereanu</surname><given-names>W.</given-names></name><name><surname>Packer</surname><given-names>A.</given-names></name><name><surname>Banerjee-Basu</surname><given-names>S.</given-names></name></person-group> (<year>2016</year>). <article-title>A systematic variant annotation approach for ranking genes associated with autism spectrum disorders</article-title>. <source/>Mol. Autism
<volume>7</volume>:<fpage>44</fpage>. <pub-id pub-id-type="doi">10.1186/s13229-016-0103-y</pub-id><pub-id pub-id-type="pmid">27790361</pub-id></mixed-citation>
</ref>
<ref id="B28">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Magen</surname><given-names>I.</given-names></name><name><surname>Gozes</surname><given-names>I.</given-names></name></person-group> (<year>2013</year>). <article-title>Microtubule-stabilizing peptides and small molecules protecting axonal transport and brain function: focus on davunetide (NAP)</article-title>. <source/>Neuropeptides
<volume>47</volume>, <fpage>489</fpage>–<lpage>495</lpage>. <pub-id pub-id-type="doi">10.1016/j.npep.2013.10.011</pub-id><pub-id pub-id-type="pmid">24210139</pub-id></mixed-citation>
</ref>
<ref id="B29">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Magen</surname><given-names>I.</given-names></name><name><surname>Gozes</surname><given-names>I.</given-names></name></person-group> (<year>2014</year>). <article-title>Davunetide: peptide therapeutic in neurological disorders</article-title>. <source/>Curr. Med. Chem.
<volume>21</volume>, <fpage>2591</fpage>–<lpage>2598</lpage>. <pub-id pub-id-type="doi">10.2174/0929867321666140217124945</pub-id><pub-id pub-id-type="pmid">24533805</pub-id></mixed-citation>
</ref>
<ref id="B30">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Malishkevich</surname><given-names>A.</given-names></name><name><surname>Amram</surname><given-names>N.</given-names></name><name><surname>Hacohen-Kleiman</surname><given-names>G.</given-names></name><name><surname>Magen</surname><given-names>I.</given-names></name><name><surname>Giladi</surname><given-names>E.</given-names></name><name><surname>Gozes</surname><given-names>I.</given-names></name></person-group> (<year>2015</year>). <article-title>Activity-dependent neuroprotective protein (ADNP) exhibits striking sexual dichotomy impacting on autistic and Alzheimer's pathologies</article-title>. <source/>Transl. Psychiatry
<volume>5</volume>:<fpage>e501</fpage>. <pub-id pub-id-type="doi">10.1038/tp.2014.138</pub-id><pub-id pub-id-type="pmid">25646590</pub-id></mixed-citation>
</ref>
<ref id="B31">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Malishkevich</surname><given-names>A.</given-names></name><name><surname>Marshall</surname><given-names>G. A.</given-names></name><name><surname>Schultz</surname><given-names>A. P.</given-names></name><name><surname>Sperling</surname><given-names>R. A.</given-names></name><name><surname>Aharon-Peretz</surname><given-names>J.</given-names></name><name><surname>Gozes</surname><given-names>I.</given-names></name></person-group> (<year>2016</year>). <article-title>Blood-borne activity-dependent neuroprotective protein (ADNP) is correlated with premorbid intelligence, clinical stage, and Alzheimer's disease biomarkers</article-title>. <source/>J. Alzheimer's Dis.
<volume>50</volume>, <fpage>249</fpage>–<lpage>260</lpage>. <pub-id pub-id-type="doi">10.3233/JAD-150799</pub-id><pub-id pub-id-type="pmid">26639975</pub-id></mixed-citation>
</ref>
<ref id="B32">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mandel</surname><given-names>S.</given-names></name><name><surname>Gozes</surname><given-names>I.</given-names></name></person-group> (<year>2007</year>). <article-title>Activity-dependent neuroprotective protein constitutes a novel element in the SWI/SNF chromatin remodeling complex</article-title>. <source/>J. Biol. Chem.
<volume>282</volume>, <fpage>34448</fpage>–<lpage>34456</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M704756200</pub-id><pub-id pub-id-type="pmid">17878164</pub-id></mixed-citation>
</ref>
<ref id="B33">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mandel</surname><given-names>S.</given-names></name><name><surname>Rechavi</surname><given-names>G.</given-names></name><name><surname>Gozes</surname><given-names>I.</given-names></name></person-group> (<year>2007</year>). <article-title>Activity-dependent neuroprotective protein (ADNP) differentially interacts with chromatin to regulate genes essential for embryogenesis</article-title>. <source/>Dev. Biol.
<volume>303</volume>, <fpage>814</fpage>–<lpage>824</lpage>. <pub-id pub-id-type="doi">10.1016/j.ydbio.2006.11.039</pub-id><pub-id pub-id-type="pmid">17222401</pub-id></mixed-citation>
</ref>
<ref id="B34">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mandel</surname><given-names>S.</given-names></name><name><surname>Spivak-Pohis</surname><given-names>I.</given-names></name><name><surname>Gozes</surname><given-names>I.</given-names></name></person-group> (<year>2008</year>). <article-title>ADNP differential nucleus/cytoplasm localization in neurons suggests multiple roles in neuronal differentiation and maintenance</article-title>. <source/>J. Mol. Neurosci.
<volume>35</volume>, <fpage>127</fpage>–<lpage>141</lpage>. <pub-id pub-id-type="doi">10.1007/s12031-007-9013-y</pub-id><pub-id pub-id-type="pmid">18286385</pub-id></mixed-citation>
</ref>
<ref id="B35">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Merenlender-Wagner</surname><given-names>A.</given-names></name><name><surname>Malishkevich</surname><given-names>A.</given-names></name><name><surname>Shemer</surname><given-names>Z.</given-names></name><name><surname>Udawela</surname><given-names>M.</given-names></name><name><surname>Gibbons</surname><given-names>A.</given-names></name><name><surname>Scarr</surname><given-names>E.</given-names></name><etal></etal></person-group>. (<year>2015</year>). <article-title>Autophagy has a key role in the pathophysiology of Schizophrenia</article-title>. <source/>Mol. Psychiatry
<volume>20</volume>, <fpage>126</fpage>–<lpage>132</lpage>. <pub-id pub-id-type="doi">10.1038/mp.2013.174</pub-id><pub-id pub-id-type="pmid">24365867</pub-id></mixed-citation>
</ref>
<ref id="B36">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mosch</surname><given-names>K.</given-names></name><name><surname>Franz</surname><given-names>H.</given-names></name><name><surname>Soeroes</surname><given-names>S.</given-names></name><name><surname>Singh</surname><given-names>P. B.</given-names></name><name><surname>Fischle</surname><given-names>W.</given-names></name></person-group> (<year>2011</year>). <article-title>HP1 recruits activity-dependent neuroprotective protein to H3K9me3 marked pericentromeric heterochromatin for silencing of major satellite repeats</article-title>. <source/>PLoS ONE
<volume>6</volume>:<fpage>e15894</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0015894</pub-id><pub-id pub-id-type="pmid">21267468</pub-id></mixed-citation>
</ref>
<ref id="B37">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ostapcuk</surname><given-names>V.</given-names></name><name><surname>Mohn</surname><given-names>F.</given-names></name><name><surname>Carl</surname><given-names>S. H.</given-names></name><name><surname>Basters</surname><given-names>A.</given-names></name><name><surname>Hess</surname><given-names>D.</given-names></name><name><surname>Iesmantavicius</surname><given-names>V.</given-names></name><etal></etal></person-group>. (<year>2018</year>). <article-title>Activity-dependent neuroprotective protein recruits HP1 and CHD4 to control lineage-specifying genes</article-title>. <source/>Nature
<volume>557</volume>, <fpage>739</fpage>–<lpage>743</lpage>. <pub-id pub-id-type="doi">10.1038/s41586-018-0153-8</pub-id><pub-id pub-id-type="pmid">29795351</pub-id></mixed-citation>
</ref>
<ref id="B38">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pinhasov</surname><given-names>A.</given-names></name><name><surname>Mandel</surname><given-names>S.</given-names></name><name><surname>Torchinsky</surname><given-names>A.</given-names></name><name><surname>Giladi</surname><given-names>E.</given-names></name><name><surname>Pittel</surname><given-names>Z.</given-names></name><name><surname>Goldsweig</surname><given-names>A. M.</given-names></name><etal></etal></person-group> (<year>2003</year>). <article-title>Activity-dependent neuroprotective protein: a novel gene essential for brain formation. <italic>Brain Res</italic></article-title>. <source/>Dev. Brain Res.
<volume>144</volume>, <fpage>83</fpage>–<lpage>90</lpage>. <pub-id pub-id-type="doi">10.1016/S0165-3806(03)00162-7</pub-id><pub-id pub-id-type="pmid">12888219</pub-id></mixed-citation>
</ref>
<ref id="B39">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schirer</surname><given-names>Y.</given-names></name><name><surname>Malishkevich</surname><given-names>A.</given-names></name><name><surname>Ophir</surname><given-names>Y.</given-names></name><name><surname>Lewis</surname><given-names>J.</given-names></name><name><surname>Giladi</surname><given-names>E.</given-names></name><name><surname>Gozes</surname><given-names>I.</given-names></name></person-group> (<year>2014</year>). <article-title>Novel marker for the onset of frontotemporal dementia: early increase in activity-dependent neuroprotective protein (ADNP) in the face of Tau mutation</article-title>. <source/>PLoS ONE
<volume>9</volume>:<fpage>e87383</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0087383</pub-id><pub-id pub-id-type="pmid">24489906</pub-id></mixed-citation>
</ref>
<ref id="B40">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sragovich</surname><given-names>S.</given-names></name><name><surname>Merenlender-Wagner</surname><given-names>A.</given-names></name><name><surname>Gozes</surname><given-names>I.</given-names></name></person-group> (<year>2017</year>). <article-title>ADNP plays a key role in autophagy: from autism to schizophrenia and alzheimer's disease</article-title>. <source/>BioEssays
<volume>39</volume>:<fpage>1700054</fpage>. <pub-id pub-id-type="doi">10.1002/bies.201700054</pub-id><pub-id pub-id-type="pmid">28940660</pub-id></mixed-citation>
</ref>
<ref id="B41">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>St Clair</surname><given-names>D.</given-names></name><name><surname>Johnstone</surname><given-names>M.</given-names></name></person-group> (<year>2018</year>). <article-title>Using mouse transgenic and human stem cell technologies to model genetic mutations associated with schizophrenia and autism</article-title>. <source/>Philos. Trans. R. Soc. Lond. B Biol. Sci.
<volume>373</volume>:<fpage>20170037</fpage>. <pub-id pub-id-type="doi">10.1098/rstb.2017.0037</pub-id><pub-id pub-id-type="pmid">29352035</pub-id></mixed-citation>
</ref>
<ref id="B42">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stessman</surname><given-names>H. A.</given-names></name><name><surname>Xiong</surname><given-names>B.</given-names></name><name><surname>Coe</surname><given-names>B. P.</given-names></name><name><surname>Wang</surname><given-names>T.</given-names></name><name><surname>Hoekzema</surname><given-names>K.</given-names></name><name><surname>Fenckova</surname><given-names>M.</given-names></name><etal></etal></person-group>. (<year>2017</year>). <article-title>Targeted sequencing identifies 91 neurodevelopmental-disorder risk genes with autism and developmental-disability biases</article-title>. <source/>Nat. Genet.
<volume>49</volume>, <fpage>515</fpage>–<lpage>526</lpage>. <pub-id pub-id-type="doi">10.1038/ng.3792</pub-id><pub-id pub-id-type="pmid">28191889</pub-id></mixed-citation>
</ref>
<ref id="B43">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vacic</surname><given-names>V.</given-names></name><name><surname>McCarthy</surname><given-names>S.</given-names></name><name><surname>Malhotra</surname><given-names>D.</given-names></name><name><surname>Murray</surname><given-names>F.</given-names></name><name><surname>Chou</surname><given-names>H. H.</given-names></name><name><surname>Peoples</surname><given-names>A.</given-names></name><etal></etal></person-group>. (<year>2011</year>). <article-title>Duplications of the neuropeptide receptor gene VIPR2 confer significant risk for schizophrenia</article-title>. <source/>Nature
<volume>471</volume>, <fpage>499</fpage>–<lpage>503</lpage>. <pub-id pub-id-type="doi">10.1038/nature09884</pub-id><pub-id pub-id-type="pmid">21346763</pub-id></mixed-citation>
</ref>
<ref id="B44">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Van Dijck</surname><given-names>A.</given-names></name><name><surname>Vulto-van Silfhout</surname><given-names>A. T.</given-names></name><name><surname>Cappuyns</surname><given-names>E.</given-names></name><name><surname>van der Werf</surname><given-names>I. M.</given-names></name><name><surname>Mancini</surname><given-names>G. M.</given-names></name><name><surname>Tzschach</surname><given-names>A.</given-names></name><etal></etal></person-group>. (<year>2018</year>). <article-title>Clinical Presentation of a complex neurodevelopmental disorder caused by mutations in ADNP</article-title>. <source/>Biol. Psychiatry. <pub-id pub-id-type="doi">10.1016/j.biopsych.2018.02.1173.</pub-id> [Epub ahead of print].<pub-id pub-id-type="pmid">29724491</pub-id></mixed-citation>
</ref>
<ref id="B45">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vandeweyer</surname><given-names>G.</given-names></name><name><surname>Helsmoortel</surname><given-names>C.</given-names></name><name><surname>Van Dijck</surname><given-names>A. A. T</given-names></name><name><surname>Vulto-van Silfhout</surname><given-names>Coe B. P.</given-names></name><name><surname>Bernier</surname><given-names>R.</given-names></name><etal></etal></person-group>. (<year>2014</year>). <article-title>The transcriptional regulator ADNP links the BAF (SWI/SNF) complexes with autism</article-title>. <source/>Am. J. Med. Genet. Part C Semin. Med. Genet.
<volume>166C</volume>, <fpage>315</fpage>–<lpage>326</lpage>. <pub-id pub-id-type="doi">10.1002/ajmg.c.31413</pub-id><pub-id pub-id-type="pmid">25169753</pub-id></mixed-citation>
</ref>
<ref id="B46">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vulih-Shultzman</surname><given-names>I.</given-names></name><name><surname>Pinhasov</surname><given-names>A.</given-names></name><name><surname>Mandel</surname><given-names>S.</given-names></name><name><surname>Grigoriadis</surname><given-names>N.</given-names></name><name><surname>Touloumi</surname><given-names>O.</given-names></name><name><surname>Pittel</surname><given-names>Z.</given-names></name><etal></etal></person-group>. (<year>2007</year>). <article-title>Activity-dependent neuroprotective protein snippet NAP reduces tau hyperphosphorylation and enhances learning in a novel transgenic mouse model</article-title>. <source/>J. Pharmacol. Exp. Therap.
<volume>323</volume>, <fpage>438</fpage>–<lpage>449</lpage>. <pub-id pub-id-type="doi">10.1124/jpet.107.129551</pub-id><pub-id pub-id-type="pmid">17720885</pub-id></mixed-citation>
</ref>
<ref id="B47">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wenderski</surname><given-names>W.</given-names></name><name><surname>Maze</surname><given-names>I.</given-names></name></person-group> (<year>2016</year>). <article-title>Histone turnover and chromatin accessibility: critical mediators of neurological development, plasticity, and disease</article-title>. <source/>BioEssays
<volume>38</volume>, <fpage>410</fpage>–<lpage>419</lpage>. <pub-id pub-id-type="doi">10.1002/bies.201500171</pub-id><pub-id pub-id-type="pmid">26990528</pub-id></mixed-citation>
</ref>
<ref id="B48">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zamostiano</surname><given-names>R.</given-names></name><name><surname>Pinhasov</surname><given-names>A.</given-names></name><name><surname>Gelber</surname><given-names>E.</given-names></name><name><surname>Steingart</surname><given-names>R. A.</given-names></name><name><surname>Seroussi</surname><given-names>E.</given-names></name><name><surname>Giladi</surname><given-names>E.</given-names></name><etal></etal></person-group>. (<year>2001</year>). <article-title>Cloning and characterization of the human activity-dependent neuroprotective protein</article-title>. <source/>J. Biol. Chem.
<volume>276</volume>, <fpage>708</fpage>–<lpage>714</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M007416200</pub-id><pub-id pub-id-type="pmid">11013255</pub-id></mixed-citation>
</ref>
<ref id="B49">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zusev</surname><given-names>M.</given-names></name><name><surname>Gozes</surname><given-names>I.</given-names></name></person-group> (<year>2004</year>). <article-title>Differential regulation of activity-dependent neuroprotective protein in rat astrocytes by VIP and PACAP</article-title>. <source/>Regul. Peptides
<volume>123</volume>, <fpage>33</fpage>–<lpage>41</lpage>. <pub-id pub-id-type="doi">10.1016/j.regpep.2004.05.021</pub-id><pub-id pub-id-type="pmid">15518891</pub-id></mixed-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>